Search - tctmd.com

Displaying 21 - 40 of 40

Sort: Relevancy | Date

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

Presenter: Ariana Gonzálvez-García

September 29, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Todd Neale

October 01, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

Presentation JIM 2017

“Evolution of TAVI: transfemoral outcomes using ACURATE neo”

Presenter: Corrado Tamburino

February 09, 2017

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

$Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis$

Presentation JIM 2016

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

Presenter: Paolo Pagnotta

February 12, 2016

Presentation JIM 2016

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

Presenter: Christian Hengstenberg

February 10, 2016

Advertisement

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Which TAVR Device Is Best? Review Tackles Optimal Selection

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

“Evolution of TAVI: transfemoral outcomes using ACURATE neo”

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content